Volume 9.46 | Nov 26

ESC & iPSC News 9.46 November 26, 2014
ESC & iPSC News
     In this issue: Publications | Reviews | Industry News | Policy News | Events | Jobs
Cell Therapy News on Facebook  ESC on Twitter
Pluripotent Cells Created by Nuclear Transfer Can Prompt Immune Reaction
Mouse cells and tissues created through nuclear transfer can be rejected by the body because of a previously unknown immune response to the cell’s mitochondria. The findings reveal a likely, but surmountable, hurdle if such therapies are ever used in humans. [Press release from Stanford Medicine discussing online prepublication in Cell Stem Cell] Press Release | Abstract | Graphical Abstract
New TeSR™-E8™ is Here For Feeder-Free Culture of Human ES Cells and iPS Cells
PUBLICATIONS (Ranked by impact factor of the journal)
CpG Island-Mediated Global Gene Regulatory Modes in Mouse Embryonic Stem Cells
The authors performed a compendium analysis of >200 large sequencing data sets to elucidate the regulatory logic of global gene expression programs in mouse embryonic stem cells. [Nat Commun] Full Article

Multi-Kilobase Homozygous Targeted Gene Replacement in Human Induced Pluripotent Stem Cells
Scientists demonstrate efficient ‘knock-in’ targeted replacement of multi-kilobase genes in human induced pluripotent stem cells. Using a model system replacing endogenous human genes with their mouse counterpart, they performed a comprehensive study of targeting vector design parameters for homologous recombination. [Nucleic Acids Res] Full Article

The Dyskerin Ribonucleoprotein Complex as an OCT4/SOX2 Coactivator in Embryonic Stem Cells
Using a biochemically defined in vitro transcription system that mediates OCT4/SOX2 and coactivator-dependent transcription of the Nanog gene, researchers report the purification and identification of the dyskerin ribonucleoprotein complex as an OCT4/SOX2 coactivator whose activity appears to be modulated by a subset of associated small nucleolar RNAs. [Elife] Abstract | Full Article

A Rare Human Syndrome Provides Genetic Evidence that WNT Signaling Is Required for Reprogramming of Fibroblasts to Induced Pluripotent Stem Cells
Researchers provide genetic evidence that WNT signaling is a requisite step during the induction of pluripotency. Fibroblasts from individuals with focal dermal hypoplasia, a rare genetic syndrome caused by mutations in the essential WNT processing enzyme PORCN, fail to reprogram with standard methods. [Cell Rep] Full Article | Graphical Abstract | Press Release

Efficient and Allele-Specific Genome Editing of Disease Loci in Human iPSCs
Scientists investigated the relative efficiencies of CRISPR/Cas9 and TALENs in human induced pluripotent stem cell (iPSC) lines for inducing both homologous donor-based precise genome editing and non-homologous end joining-mediated gene disruption. [Mol Ther] Abstract

Derivation and High Engraftment of Patient-Specific Cardiomyocyte-Sheet Using Induced Pluripotent Stem Cells Generated from Adult Cardiac Fibroblast
Scientists show that human cardiac induced pluripotent stem cells (hciPSCs) can be generated from cardiac fibroblasts and subsequently differentiated into exceptionally pure sheets of cardiomyocytes (CMs). The hciPSCs passed through all the normal stages of differentiation before assuming a CM identity. [Circ Heart Fail] Abstract

Stochastic Promoter Activation Affects Nanog Expression Variability in Mouse Embryonic Stem Cells
Nanog, a key transcription factor for pluripotency, displays heterogeneous expression in mouse embryonic stem cells, via mechanisms that are not fully understood. To understand this variability, researchers quantitatively analyzed Nanog transcription and found that Nanog was both infrequently transcribed, and transcribed in a pulsatile and stochastic manner. [Sci Rep] Full Article

Metabolic Profiling and Flux Analysis of MEL-2 Human Embryonic Stem Cells during Exponential Growth at Physiological and Atmospheric Oxygen Concentrations
Investigators undertook an in-depth characterization of MEL-2 human embryonic stem cells metabolic behavior during the exponential growth phase, combining metabolic profiling and flux analysis tools at physiological and atmospheric oxygen concentrations. [PLoS One] Full Article

Histone Deacetylase 1 and 3 Regulate the Mesodermal Lineage Commitment of Mouse Embryonic Stem Cells
Scientists found that trichostatin A, an inhibitor of histone deacetylase, could induce early differentiation of embryonic stem cells and promote mesodermal lineage differentiation. [PLoS One] Full Article

BMP-4 Increases Activin A Gene Expression during Osteogenic Differentiation of Mouse Embryonic Stem Cells
Scientists investigated the effect of bone morphogenetic protein (BMP)-4 on activin A gene expression during in vitro osteogenic differentiation of mouse embryonic stem cells. [Growth Factors] Abstract

Free Wallchart: Small Molecules, Big Impact in PSC Research
Human Oligodendrocytes in Remyelination Research
The authors discuss potential sources of human oligodendrocytes, including novel oligodendrocyte generation strategies employing induced pluripotent stem cells and direct conversion technology. [Glia] Abstract

Visit our reviews page to see a complete list of reviews in the ESC & iPSC research field.

Don't miss ASGCT 18th Annual Meeting!
New Ontario Institute to Tackle Costly Diseases of Aging
The Government of Ontario has awarded new funding to the Ontario Stem Cell Initiative and the Centre for Commercialization of Regenerative Medicine to establish the Ontario Institute for Regenerative Medicine – a research, development and commercialization institute dedicated to the translation of stem cell research into curative therapies for major degenerative diseases. [Ontario Institute for Regenerative Medicine (Marketwire L.P.)] Press Release

Mount Sinai Researchers Awarded Grant to Find New Stem Cell Therapies for Vision Recovery
The National Eye Institute, a division of the National Institutes of Health, has awarded researchers at the Icahn School of Medicine at Mount Sinai a five-year grant totaling $1 million that will support an effort to re-create a patients’ ocular stem cells and restore vision in those blinded by corneal disease. [The Mount Sinai Hospital (EurekAlert)] Press Release

From our sponsor:
Learn About Groundbreaking Applications for Feeder-Free hESC & hiPSC Culture.
Watch Webinar Now
Gates Foundation to Require Immediate Free Access for Journal Articles
Breaking new ground for the open-access movement, the Bill & Melinda Gates Foundation, a major funder of global health research, plans to require that the researchers it funds publish only in immediate open-access journals. [ScienceInsider] Editorial

Proposed Rules Will Vastly Expand Trove of Clinical Trial Data Reported in U.S. Database
The amount of clinical data that drug companies must share with the public could soon vastly expand under a U.S. regulation proposed. Trial sponsors would need to report summary results for drugs and devices that are never approved – and not just for products that reach the market – under the proposal. [ScienceInsider] Editorial
NEW Regenerative Medicine & Stem Cell 2015
March 19-21, 2015
Busan, South Korea

Visit our events page to see a complete list of events in the ESC & iPSC community.
NEW Postdoctoral Research Associate – Stem Cell Engineering (Rensselaer Polytechnic Institute)

Postdoctoral Fellow – In Vitro Modeling of Human Skeletal Muscle Disease (Duke University)

Head of Cellular and Molecular Therapies Laboratory (NHS Blood & Transplant)

PhD Studentship – The Initial Network for Cellular Reprogramming to Pluripotency (University of Edinburgh)

Postdoctoral Position – Stem Cell and RNA Biology (Lund University)

Postdoctoral Position – Muscle Cell Therapy (I-Stem)

Postdoctoral Scientist – Stem Cell Biology (Texas Biomedical Research Institute)

Postdoctoral Fellow – Pluripotent Stem Cell Laboratory (University of California – San Diego)

Scientist – Reprogramming and Pluripotent Stem Cell Biology (STEMCELL Technologies Inc.)

Scientist – Pluripotent Stem Cell Biology Endoderm Lineages (STEMCELL Technologies Inc.)

Scientist – Human Pluripotent Stem Cell Biology (STEMCELL Technologies Inc.)

Scientist – Pluripotent Stem Cell Media Development, High Throughput Screening (STEMCELL Technologies Inc.)

Scientist – Cell Culture Support Products (STEMCELL Technologies Inc.)

Scientist – Immunology/Cell Separation (STEMCELL Technologies Inc.)

Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

Have we missed an important article or publication in ESC & iPSC News? Click here to submit!

Comments or suggestions? Submit your feedback here
Learn more about ESC & iPSC News: Archives | Events | Contact Us